Cite
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature.
MLA
Favaloro, Emmanuel J., et al. “Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature.” Seminars in Thrombosis & Hemostasis, vol. 48, no. 1, Feb. 2022, pp. 55–71. EBSCOhost, https://doi.org/10.1055/s-0041-1729856.
APA
Favaloro, E. J., Henry, B. M., & Lippi, G. (2022). Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature. Seminars in Thrombosis & Hemostasis, 48(1), 55–71. https://doi.org/10.1055/s-0041-1729856
Chicago
Favaloro, Emmanuel J., Brandon Michael Henry, and Giuseppe Lippi. 2022. “Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature.” Seminars in Thrombosis & Hemostasis 48 (1): 55–71. doi:10.1055/s-0041-1729856.